Old Web
English
Sign In
Acemap
>
Paper
>
Ibrutinib and idelalisib in the management of CLL‐associated autoimmune cytopenias: a study from the FILO group
Ibrutinib and idelalisib in the management of CLL‐associated autoimmune cytopenias: a study from the FILO group
2019
Anne Quinquenel
Sophie Godet
Caroline Dartigeas
Loic Ysebaert
Jehan Dupuis
Haykanush Ohanyan
Aude Collignon
Laurent Gilardin
Stéphane Leprêtre
Marie-Sarah Dilhuydy
Marguerite Vignon
Sophie de Guibert
Natalia Dmytruk
Eric Durot
David Ghez
Damien Roos-Weil
Marie-Christine Béné
Elise Toussaint
Fatiha Merabet
Vincent Levy
Alain Delmer
Thérèse Aurran
Keywords:
Medicine
Immunology
Diabetes mellitus
Idelalisib
Ibrutinib
Survival rate
Leukemia
disease free survival
MEDLINE
Correction
Source
Cite
Save
Machine Reading By IdeaReader
6
References
7
Citations
NaN
KQI
[]